Accumulating evidences indicate that different long non-coding RNAs (lncRNAs) might play a relevant role in tumorigenesis, with their expression and function already associated to cancer development and progression. CCAAT/enhancer-binding protein-α (CEBPA) is a critical regulator of myeloid differentiation whose inactivation contributes to the development of acute myeloid leukemia (AML). Mutations in C/EBPα occur in around 10% of AML cases, leading to the expression of a 30-kDa dominant negative isoform (C/EBPα-p30). In this study, we identified the oncogenic urothelial carcinoma associated 1 (UCA1) lncRNA as a novel target of the C/EBPα-p30. We show that wild-type C/EBPα and C/EBPα-p30 isoform can bind the UCA1 promoter but have opposite effects on UCA1 expression. While wild-type C/EBPα represses, C/EBPα-p30 can induce UCA1 transcription. Notably, we also show that UCA1 expression increases in cytogenetically normal AML cases carrying biallelic CEBPA mutations. Furthermore, we demonstrate that UCA1 sustains proliferation of AML cells by repressing the expression of the cell cycle regulator p27kip1. Thus, we identified, for the first time, an oncogenic lncRNA functioning in concert with the dominant negative isoform of C/EBPα in AML.

C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia / Hughes, JAMES M.; Legnini, Ivano; Salvatori, Beatrice; Masciarelli, Silvia; Marchioni, M; Fazi, Francesco; Morlando, Mariangela; Bozzoni, Irene; Fatica, Alessandro. - In: ONCOTARGET. - ISSN 1949-2553. - STAMPA. - 6:21(2015), pp. 18534-18544. [10.18632/oncotarget.4069]

C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia

HUGHES, JAMES M.;LEGNINI, IVANO;SALVATORI, BEATRICE;MASCIARELLI, SILVIA;FAZI, Francesco;MORLANDO, MARIANGELA;BOZZONI, Irene;FATICA, Alessandro
2015

Abstract

Accumulating evidences indicate that different long non-coding RNAs (lncRNAs) might play a relevant role in tumorigenesis, with their expression and function already associated to cancer development and progression. CCAAT/enhancer-binding protein-α (CEBPA) is a critical regulator of myeloid differentiation whose inactivation contributes to the development of acute myeloid leukemia (AML). Mutations in C/EBPα occur in around 10% of AML cases, leading to the expression of a 30-kDa dominant negative isoform (C/EBPα-p30). In this study, we identified the oncogenic urothelial carcinoma associated 1 (UCA1) lncRNA as a novel target of the C/EBPα-p30. We show that wild-type C/EBPα and C/EBPα-p30 isoform can bind the UCA1 promoter but have opposite effects on UCA1 expression. While wild-type C/EBPα represses, C/EBPα-p30 can induce UCA1 transcription. Notably, we also show that UCA1 expression increases in cytogenetically normal AML cases carrying biallelic CEBPA mutations. Furthermore, we demonstrate that UCA1 sustains proliferation of AML cells by repressing the expression of the cell cycle regulator p27kip1. Thus, we identified, for the first time, an oncogenic lncRNA functioning in concert with the dominant negative isoform of C/EBPα in AML.
2015
lncRN; CEBPA, AML; long non-coding RNA; acute myeloid leukemia; CEBPA; UCA1
01 Pubblicazione su rivista::01a Articolo in rivista
C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia / Hughes, JAMES M.; Legnini, Ivano; Salvatori, Beatrice; Masciarelli, Silvia; Marchioni, M; Fazi, Francesco; Morlando, Mariangela; Bozzoni, Irene; Fatica, Alessandro. - In: ONCOTARGET. - ISSN 1949-2553. - STAMPA. - 6:21(2015), pp. 18534-18544. [10.18632/oncotarget.4069]
File allegati a questo prodotto
File Dimensione Formato  
Hughes_C/EBPα-p30_2015.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 2.38 MB
Formato Adobe PDF
2.38 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/788639
Citazioni
  • ???jsp.display-item.citation.pmc??? 37
  • Scopus 71
  • ???jsp.display-item.citation.isi??? 71
social impact